» Go to news main
Dalhousie receives $5.1 million investment in health research
Eight researchers from Dalhousie University are the recipients of over $5 million in funding from the Government of Canada for their innovative health research.
The funding, which is provided by the Canadian Institutes of Health Research (CIHR) project grants, will help Dal’s world-class researchers study a wide range of topics, including: cancer therapy and gene editing; low testosterone and its impact on the heart; pharmaceutical safety and transparency; insulin resistance and heart muscle damage; neurodevelopmental disorders; innate immune memory; more effective breast cancer treatments; and alternative therapies for bacterial infections.
The announcement was made on Wednesday, January 24 at Memorial University of Newfoundland. In total, 512 research projects from across the country will receive $372 million in funding.
Successfully funded researchers:
- Graham Dellaire, Departments of Pathology and Biochemistry & Molecular Biology
- Susan Howlett, Department of Pharmacology
- Matthew Herder, Health Law Institute and Department of Pharmacology
- Petra Kienesberger, Department of Biochemistry & Molecular Biology
- Angelo Iulianella, Department of Medical Neuroscience
- Andrew Makrigiannis, Department of Microbiology and Immunology
- Kirill Rosen, Department of Biochemistry & Molecular Biology
- Xianping Dong, Department of Physiology and Biophysics
Read more on Dal News.
- Dalhousie Medical School welcomes James Robinson Johnston Chair in Black Canadian Studies
- Matters of the heart: Diabetes research at DMNB
- Dalhousie Psychiatry professors exploring the DNA of bipolar disorder
- Health research boosted by $3.4 million in federal funding
- Painting a portrait of Alzheimer's disease
- Wait time well spent: Dal Med community addresses mental health challenges
- Dal rheumatologist wins national teaching award
- Dal Health researchers have study published in JAMA Pediatrics